Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2018 | ENYO Pharma | $47.0M Series B | OrbiMed | Andera Partners, Earlybird Venture Capital, Kurma Partners, Pfizer Venture Investments, Pureos Bioventures, SR One, Third Rock Ventures, Wellington Partners, Vincent Brichard, Bpifrance, Inserm Transfert Initiative, Morningside, Sofinnova Ventures |
| Dec 16, 2015 | GamaMabs Pharma | $16.4M Series B | — | Alto Invest, IRDInov, iXO Private Equity |
| Sep 9, 2015 | Biom'Up | $34.9M Series C | — | Laurent Higueret, Euroainvest, Karl Nagler, l'Améliane, Casper Breum, Merieux Equity Partners, OTC AM, Sham, Sofimac, Viveris Management |
| Apr 9, 2013 | Medday Pharmaceuticals | $10.5M Other Equity | — | Sofinnova Partners |
| Dec 21, 2012 | Poxel | $17.1M Series B | — | Omnes Capital |